Feasibility Clinical Study of the Alma System in Treating Primary Postpartum Hemorrhage

NARecruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

April 14, 2024

Primary Completion Date

April 30, 2025

Study Completion Date

April 30, 2025

Conditions
Postpartum Haemorrhage (PPH)PPHPostpartum Hemorrhage (Primary)
Interventions
DEVICE

Alma System

Subjects diagnosed with postpartum hemorrhage will receive the Alma System. This system comprises a soft silicone cylindrical device placed within the uterus. Gentle suction is applied, prompting the uterus to contract and reduce in size. This contraction compresses the blood vessels, halting the bleeding.

Trial Locations (1)

Unknown

RECRUITING

University Clinical Hospital of Mostar, Mostar

All Listed Sponsors
lead

ResQ Medical Ltd

OTHER